TITLE

Session 40: Female fertility - Clinical aspects 2

PUB. DATE
July 2007
SOURCE
Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi56
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on the clinical aspects of female fertility, including the practice of embryo donation in French assisted reproductive technology (ART) centres, using three-dimensional (3D) ultrasound in assessing ovarian volume and the temporary suppressive effects of a gonadotropin-releasing hormone (GnRH) antagonist when used concurrently with potentially toxic doses of chemotherapeutic agents for protection of ovarian function, as well as the effect of infertility on the sexual function of women.
ACCESSION #
44357006

 

Related Articles

  • Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Tarlatzis, B. C.; Kolibianakis, E. M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p8 

    The wide application of gonadotrophin-releasing hormone (GnRH) analogues in assisted reproduction has raised concerns about their potential extra-pituitary actions. Although data from animal studies support the presence of ovarian GnRH receptors and of direct ovarian effects of GnRH analogues,...

  • Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born. Ludwig, M.; Katalinic, A.; Felberbaum, R. E.; Diedrich, K. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p61 

    The safety of ovarian stimulation procedures or the procedure of assisted reproduction in general can be estimated by various parameters. Two of the most important are the health of children born after the procedure and the incidence of ovarian hyperstimulation syndrome (OHSS). The latter is...

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

  • ART, clinical: GnRH agonist/antagonist.  // Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi120 

    The article presents abstracts on the use of gonadotropin-releasing hormone (GnRH) agonists and antagonists in assisted reproductive technology (ART), including the administration of gonadoliberine analogues (GnRH-a) to patients with Hodgkin lymphoma (HL) during chemotherapy and prevention of...

  • Gonadotrophin-releasing hormone antagonists: will they replace the agonists? Felberbaum, Ricardo; Diedrich, Klaus // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jan/Feb2003, Vol. 6 Issue 1, p43 

    Discusses the functions of gonadotrophin-releasing hormone (GnRH) antagonists. Pharmacological mode of action of GnRH agonists and antagonists; Amount of gonadotrophins used for ovarian stimulation; Costs of using GnRH antagonists. INSET: Ongoing problems after wrong sperm sample used in IVF.

  • Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial. Tazegül, Aybike; Görkemli, Hüseyin; Özdemir, Suna; Aktan, T. Murad; Tazegül, Aybike; Görkemli, Hüseyin; Ozdemir, Suna // Archives of Gynecology & Obstetrics;Nov2008, Vol. 278 Issue 5, p467 

    Objective: To investigate the efficacy of gonadotropin releasing hormone antagonist (GnRH) in poor responders undergoing in vitro fertilization.Study Design: Ninety-six patients with poor ovarian response in previous treatment cycles were prospectively randomized into...

  • Effect of cetrorelix dose on premature LH surge during ovarian stimulation. Yu-Hung Lin; Seow, K. M.; Chen, H. J.; Hsieh, B. C.; Huang, L. W.; Tzeng, C. R.; Hwang, J. L. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2008, Vol. 16 Issue 6, p772 

    Previous studies have shown that ovarian stimulation with clomiphene citrate (CC), human menopausal gonadotrophin (HMG), and multiple-dose gonadotrophin-releasing hormone (GnRH) antagonist is associated with a high rate of premature LH surge. This study assessed whether administration of the...

  • Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study. Engel, Jorg Bernhard; Olivennes, F; Fanchin, R; Frydman, N; Le Du, A; Blanchet, V; Frydman, R // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2003, Vol. 6 Issue 4, p444 

    Investigates the feasibility of using clomiphene citrate in combination with gonadotrophins, in a luteinizing hormone-releasing hormone (LHRH) antagonist protocol. Role of LHRH antagonist in assisted reproductive technique; Materials and methods used in the study; Results.

  • The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome. Pinkas, Haim; Sapir, Onit; Avrech, Ori M.; Ben-Haroush, Avi; Ashkenzi, Jacob; Fisch, Benjamin; Farhi, Jacob // Journal of Assisted Reproduction & Genetics;Jan2008, Vol. 25 Issue 1, p29 

    Objective To evaluate the effect of oral contraceptive pills (OCP) pretreatment on IVF cycle outcome in GnRH-antagonist protocol. Design Retrospective cohort study. Setting Major tertiary university-affiliated center. Patients All patients treated with GnRH antagonist in our IVF unit during the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics